Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 8025898 was granted and assigned to Noven Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office. | 8025898 | September 27, 2011 | |||||||
Patent 7456159 was granted and assigned to Noven Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office. | 7456159 | November 25, 2008 | |||||||
Patent 7993671 was granted and assigned to Noven Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office. | 7993671 | August 9, 2011 | |||||||
Patent 6851615 was granted and assigned to Noven Pharmaceuticals on February, 2005 by the United States Patent and Trademark Office. | 6851615 | February 8, 2005 | |||||||
Patent 9333263 was granted and assigned to Noven Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office. | 9333263 | May 10, 2016 | |||||||
Patent 7063859 was granted and assigned to Noven Pharmaceuticals on June, 2006 by the United States Patent and Trademark Office. | 7063859 | June 20, 2006 | |||||||
Patent 8632802 was granted and assigned to Noven Pharmaceuticals on January, 2014 by the United States Patent and Trademark Office. | 8632802 | January 21, 2014 | |||||||
Patent 8703175 was granted and assigned to Noven Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office. | 8703175 | April 22, 2014 | |||||||
Patent 11376327 was granted and assigned to Noven Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office. | 11376327 | July 5, 2022 | |||||||
Patent 9474722 was granted and assigned to Noven Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office. | 9474722 | October 25, 2016 | |||||||
11427666 | August 30, 2022 | ||||||||
Patent 9456993 was granted and assigned to Noven Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office. | 9456993 | October 4, 2016 | |||||||
Patent 10004696 was granted and assigned to Noven Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office. | 10004696 | June 26, 2018 | |||||||
Patent 10406115 was granted and assigned to Noven Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office. | 10406115 | September 10, 2019 | |||||||
Patent 10406116 was granted and assigned to Noven Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office. | 10406116 | September 10, 2019 | |||||||
Patent 9901552 was granted and assigned to Noven Pharmaceuticals on February, 2018 by the United States Patent and Trademark Office. | 9901552 | February 27, 2018 | |||||||
Patent 6905016 was granted and assigned to Noven Pharmaceuticals on June, 2005 by the United States Patent and Trademark Office. | 6905016 | June 14, 2005 | |||||||
Patent 10231938 was granted and assigned to Noven Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office. | 10231938 | March 19, 2019 | |||||||
Patent 9155712 was granted and assigned to Noven Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office. | 9155712 | October 13, 2015 | |||||||
Patent 11572339 was granted and assigned to Noven Pharmaceuticals on February, 2023 by the United States Patent and Trademark Office. | 11572339 | February 7, 2023 | |||||||
Patent 11559501 was granted and assigned to Noven Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office. | 11559501 | January 24, 2023 | |||||||
Patent 8343538 was granted and assigned to Noven Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office. | 8343538 | January 1, 2013 | |||||||
Patent 11337936 was granted and assigned to Noven Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office. | 11337936 | May 24, 2022 | |||||||
Patent 8187628 was granted and assigned to Noven Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office. | 8187628 | May 29, 2012 | |||||||
Patent 8865207 was granted and assigned to Noven Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office. | 8865207 | October 21, 2014 |